Early impact of RSV vaccination in older adults in England

Source: The Lancet

Early data from the roll out of the respiratory syncytial virus (RSV) vaccination programme in England shows it is making a significant reduction to hospital admission rates in older people. This analysis by UKHSA was published as a research letter in the Lancet.

The findings indicate 30% fewer hospital admissions in 75 to 79 year olds, who are eligible for the vaccine under the new programme, than would have occurred without vaccination.

The findings indicate 30% fewer hospital admissions in 75 to 79 year olds, who are eligible for the vaccine under the new programme, than would have occurred without vaccination.

The findings demonstrate the effectiveness of the RSV vaccine in UK older people following the programme’s launch in September 2024, and highlight why it’s so important for eligible older people to come forward and protect themselves.